Here are Credit Suisse's top 3 biotech picks

Home › Here are Credit Suisse's top 3 biotech picks

Celgene : Target $144. Implied upside 33% . "We believe that CELG looks cheap relative to its growth after reviewing current and pipeline products.

08.07	Farm Progress America, July 8, 2024
08.07	Carlsberg to buy Robinsons squash maker Britvic
08.07	Hurricane Beryl Update Statement
08.07	Summary for Hurricane Beryl (AT2/AL022024)
08.07	Hurricane Beryl Potential Storm Surge Flooding Map
08.07	Hurricane Beryl Probabilistic Storm Surge Graphics
08.07	Hurricane Beryl Graphics
08.07	What's the right punishment for 'too big to fail' Boeing?
More »

je.st